Invesco ltd: Form 8.3 - Xeris Pharmaceutical Inc.
20 Septiembre 2021 - 6:14AM
Invesco ltd: Form 8.3 - Xeris Pharmaceutical Inc.
Form 8.3
IRISH TAKEOVER
PANEL
DISCLOSURE
UNDER RULE 8.3
OF THE IRISH
TAKEOVER PANEL
ACT, 1997,
TAKEOVER RULES,
2013
DEALINGS BY
PERSONS WITH
INTERESTS IN
RELEVANT SECURITIES
REPRESENTING 1%
OR MORE
- KEY INFORMATION
Name of person
dealing (Note 1) |
Invesco Ltd. |
Company dealt
in |
Xeris Pharmaceuticals, Inc. |
Class of
relevant security
to which the
dealings being disclosed
relate (Note 2) |
Common Stock US98422L1070 |
Date of
dealing |
17-9-2021 |
- INTERESTS
AND SHORT
POSITIONS
(a) Interests
and short
positions (following
dealing) in the
class of
relevant security
dealt in (Note 3)
|
Long |
Short |
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant
securities |
2,036,814
3.063% |
|
(2) Derivatives
(other than
options) |
|
|
(3) Options and
agreements to
purchase/sell |
|
|
Total |
2,036,814 3.063% |
|
Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of
relevant security: |
Long |
Short |
|
No. |
|
(%) |
Number |
|
(%) |
(1) Relevant
securities |
|
|
(2) Derivatives
(other than
options) |
|
|
(3) Options and
agreements to
purchase/sell |
|
|
Total |
|
|
1. DEALINGS
(Note
4)(a) Purchases
and sales
Purchase/sale |
Number of
relevant securities |
Price per unit
(Note 52 |
Sale |
49 |
2.60 USD |
|
|
|
|
|
|
(b) Derivatives
transactions (other
than options
transactions)
Product
name,e.g.
CFD |
Nature of
transaction(Note 6) |
Number of
relevant securities(Note 7) |
Price per
unit(Note 5) |
|
|
|
|
(c) Options
transactions in
respect of
existing relevant
securities
(i) Writing,
selling, purchasing
or varying
Product
name,e.g. call
option |
Writing, selling,
purchasing, varying
etc. |
Number of
securities to
which the option
relates (Note 7) |
Exercise price |
Type, e.g.
American, European
etc. |
Expiry date |
Option money
paid/received per
unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product
name,e.g. call
option |
Number of
securities |
Exercise price
per unit (Note 5) |
|
|
|
(d) Other
dealings (including
transactions in
respect of new
securities)
(Note 4)
Nature of
transaction(Note 8) |
Details |
Price per
unit(if applicable) (Note 5) |
|
|
|
2. OTHER
INFORMATION
Agreements,
arrangements or
understandings relating
to options or
derivatives
Full details
of any
agreement, arrangement
or understanding
between the
person disclosing and
any other person
relating to the
voting rights of
any relevant
securities under
any option
referred to on
this form or
relating to the
voting rights or
future acquisition
or disposal of
any relevant
securities to
which any
derivative referred
to on this
form is
referenced. If
none, this
should be
stated.
Is a
Supplemental Form
8 attached? (Note
9)
NO
Date of
disclosure |
20-09-2021 |
Contact name |
Philippa Holmes |
Telephone number |
01491 417 447 |
If a connected
EFM, name of
offeree/offeror with
which connected |
N/A |
If a connected
EFM, state
nature of
connection (Note 10) |
|
Invesco (LSE:0UAN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Invesco (LSE:0UAN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
Real-Time news about Invesco Ltd (London Stock Exchange): 0 recent articles
Más de Artículos de Noticias